Advertisement

Diabetes

Disease State Hub

Resources
Research Summaries Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes
Events & Education
Practical Updates in Primary Care

Q&As

Expert Q&A
Robin Gal
Expert Q&A
Using a Telehealth Model in the Management of Patients With Diabetes
11/30/2023

Robin Gal, MSPH, CCRA • Grazia Aleppo, MD, FACE, FACP •  Teresa McArthur, MS, RD, CDCES

Robin Gal, MSPH, CCRA • Grazia Aleppo, MD, FACE, FACP •  Teresa McArthur, MS, RD, CDCES...
In this Q and A, Robin Gal, MSPH, CCRA, Grazia Aleppo, MD, FACE, FACP, and Teresa McArther, MS, RD, CDES answer questions about their study that investigated the use of a virtual clinic to support...
11/30/2023
Expert Q&A
Rachel Stahl Salzman, MS, RDN, CDN, CDCES
Expert Q&A
Digital Health Device Misconceptions in the Management of Patients With Diabetes
08/28/2023

Lisa Jones, MA, RDN, LND, FAND; Rachel Stahl Salzman, MS, RDN, CDN, CDCES

Lisa Jones, MA, RDN, LND, FAND; Rachel Stahl Salzman, MS, RDN, CDN, CDCES
In this interview, Lisa Jones MA, RDN, LND, FAND talks to Rachel Stahl Salzman, MS, RDN, CDN, CDCES, about possible misconceptions about digital health devices in the management of patients with diabetes,...
08/28/2023
Expert Q&A
Rachel Stahl Salzman, MS, RDN, CDN, CDCES
Expert Q&A
The Impact of Technology on the Management of Patients With Diabetes
08/17/2023

Lisa Jones, MA, RDN, LND, FAND; Rachel Stahl Salzman, MS, RDN, CDN, CDCES

Lisa Jones, MA, RDN, LND, FAND; Rachel Stahl Salzman, MS, RDN, CDN, CDCES
Diabetes technology has improved significantly in recent years, including the use of blood glucose meters, continuous glucose monitors (CGM), cutting-edge insulin pumps, and more. Lisa Jones, MA, RDN, LND,...
08/17/2023
Expert Q&A
Dr Tang
Expert Q&A
Will New ADA Guidelines Impact GLP-1 RA, SGLT-2 Inhibitor Usage?
05/01/2023
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
05/01/2023
Expert Q&A
Expert Q&A
GLP-1 Agonists and SGLT-2 Inhibitors for Patients With Diabetes
11/21/2022
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
11/21/2022
Expert Q&A
Expert Q&A
Metabolic Benefits of Weight Loss on Diabetes
07/30/2022
Results of a new study show that major weight loss has the same impact on diabetes remission whether through weight loss surgery or diet. In this Q&A, lead researcher Samuel Klein, MD, answers our...
07/30/2022
Expert Q&A
Expert Q&A
Cannabis and Diabetic Ketoacidosis in Patients With Type 1 Diabetes
06/12/2022
Consultant360 spoke with lead author Greg Kinney, PhD, about his study, which found that cannabis use may be associated with an increased risk for diabetic ketoacidosis in patients with type 1 diabetes. ...
06/12/2022
Diabetes Q&A
gilad twig, md, phd
Diabetes Q&A
The Connection Between Childhood Pancreatitis and Adult-Onset Diabetes
05/17/2022
We spoke with Gilad Twig, MD, PhD, whose recent study indicates that resolved acute pancreatitis during childhood may be a risk factor for incident diabetes in adulthood.
05/17/2022
Hypertension
Hypertension
Christianne Roumie, MD, on Intensive SBP Control and Diabetes Incidence
03/06/2022
Christianne Roumie, MD, MPH, answers our questions about her new study, which compared the incidence of diabetes and impaired fasting glucose among participants from the SPRINT Randomized Trial.
03/06/2022
Exercise
Exercise
The Impact of Exercise on All-Cause Mortality Among People With Type 2 Diabetes
02/26/2022
In a recent study, researchers assessed the relationship and resulting impact of exercise capacity on all-cause mortality risk among people with type 2 diabetes. Lead study author Yun-Ju Lai, MD, discussed...
02/26/2022